ロード中...
Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use
As of February 29, 2020, more than 85,000 cases of coronavirus disease 2019 (COVID-19) have been reported from China and 53 other countries with 2,924 deaths. On January 30, 2020, the first laboratory-confirmed case of COVID was reported from Kerala, India. In view of the earlier evidence about effe...
保存先:
| 出版年: | Indian J Med Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer - Medknow
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7288773/ https://ncbi.nlm.nih.gov/pubmed/32362644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijmr.IJMR_502_20 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|